region
stringclasses 1
value | symbol
stringlengths 1
5
| exchange
stringclasses 8
values | quote_type
stringclasses 2
values | currency
stringclasses 1
value | name
stringlengths 2
84
⌀ | sector
stringclasses 12
values | industry
stringclasses 148
values | close
float64 0
5.92k
⌀ | volume
float64 0
134M
⌀ | market_cap
float64 22.4k
2,794B
⌀ | updated_at
timestamp[ns] | long_business_summary
stringlengths 50
5.19k
⌀ | status
stringclasses 1
value | __index_level_0__
int64 0
7.31k
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
US | APLE | NYQ | EQUITY | USD | Apple Hospitality REIT, Inc. | Real Estate | REIT - Hotel & Motel | 15.64 | 1,674,020 | 3,644,768,256 | 2023-10-17T07:47:54.065877 | Apple Hospitality REIT, Inc. (NYSE: APLE) is a publicly traded real estate investment trust (REIT) that owns one of the largest and most diverse portfolios of upscale, rooms-focused hotels in the United States. Apple Hospitality's portfolio consists of 220 hotels with more than 28,900 guest rooms located in 87 markets throughout 37 states as well as one property leased to third parties. Concentrated with industry-leading brands, the Company's hotel portfolio consists of 97 Marriott-branded hotels, 119 Hilton-branded hotels and four Hyatt-branded hotels. | null | 401 |
US | APLM | NCM | EQUITY | USD | Apollomics, Inc. | Healthcare | Biotechnology | 2.02 | 30,557 | 178,961,600 | 2023-10-17T07:48:00.554001 | Apollomics, Inc., a biotechnology company, engages in the discovery and development of oncology therapies to address unmet medical needs in California, Hangzhou, Shanghai, China, and Australia. It develops APL-101 (Vebreltinib), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors; APL-102 is an oral active, small molecule multiple tyrosine kinase inhibitor for liver cancer, breast cancer, and esophageal cancer; and APL-122, a tumor inhibitor candidate to treat cancers within the brain. The company was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2015 and is based in Foster City, California. | null | 402 |
US | APLMW | NCM | EQUITY | USD | Apollomics, Inc. | null | null | 0.05 | 900 | 212,421,504 | 2023-10-17T07:48:06.562164 | null | null | 403 |
US | APLS | NMS | EQUITY | USD | Apellis Pharmaceuticals, Inc. | Healthcare | Biotechnology | 48.44 | 2,209,520 | 5,672,568,832 | 2023-10-17T07:48:14.309635 | Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria, cold agglutinin disease, C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, amyotrophic lateral sclerosis, and hematopoietic stem cell transplantation-associated thrombotic microangiopathy; and SYFOVRE for treating geographic atrophy (GA). The company also develops APL-2006, a bispecific C3 and VEGF inhibitor for treating wet age-related macular degeneration and GA; APL-1030, a C3 inhibitor for the treatment of various neurodegenerative diseases; and the combination of EMPAVELI and a small interfering RNA for reducing the production of C3 proteins by the liver. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) for development and commercialization of pegcetacoplan; and a collaboration with Beam Therapeutics Inc. focused on the use of Beam's base editing technology to discover new treatments for complement-driven diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts. | null | 404 |
US | APLT | NGM | EQUITY | USD | Applied Therapeutics, Inc. | Healthcare | Biotechnology | 2.42 | 2,174,510 | 178,010,240 | 2023-10-17T07:48:21.334520 | Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target central nervous system rare disease and diabetic complications in the United States. Its lead product candidate is AT-007 that has completed phase III for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York. | null | 405 |
US | APM | NCM | EQUITY | USD | Aptorum Group Limited | Healthcare | Biotechnology | 1.98 | 3,682 | 8,009,049 | 2023-10-17T07:48:29.523395 | Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Aptorum Group Limited is a subsidiary of Jurchen Investment Corporation. | null | 406 |
US | APMI | null | null | null | null | null | null | null | null | null | 2023-10-17T07:48:37.878485 | null | error | 407 |
US | APO | NYQ | EQUITY | USD | Apollo Global Management, Inc. | Financial Services | Asset Management | 87.56 | 2,991,516 | 49,461,239,808 | 2023-10-17T07:48:44.257829 | Apollo Global Management, Inc. is a private equity firm specializing in investments in credit, private equity and real estate markets. The firm's private equity investments include traditional buyouts, recapitalization, distressed buyouts and debt investments in real estate, corporate partner buyouts, distressed asset, corporate carve-outs, middle market, growth capital, turnaround, bridge, corporate restructuring, special situation, acquisition, and industry consolidation transactions. The firm provides its services to endowment and sovereign wealth funds, as well as other institutional and individual investors. It manages client focused portfolios. The firm launches and manages hedge funds for its clients. It also manages real estate funds and private equity funds for its clients. The firm invests in the fixed income and alternative investment markets across the globe. Its fixed income investments include income-oriented senior loans, bonds, collateralized loan obligations, structured credit, opportunistic credit, non-performing loans, distressed debt, mezzanine debt, and value oriented fixed income securities. The firm seeks to invest in chemicals, commodities, consumer and retail, oil and gas, metals, mining, agriculture, commodities, distribution and transportation, financial and business services, manufacturing and industrial, media distribution, cable, entertainment and leisure, telecom, technology, natural resources, energy, packaging and materials, and satellite and wireless industries. It also focuses on clean energy, sustainable industry, climate solutions, energy transition, industrial decarbonization, sustainable mobility, sustainable resource use, and sustainable real estate. It seeks to invest in companies based in across Africa, North America with a focus on United States, and Europe. The firm also makes investments outside North America, primarily in Western Europe and Asia. It employs a combination of contrarian, value, and distressed strategies to make its investments. The firm seeks to make investments in the range of $10 million and $1500 million. The firm seeks to invest in companies with Enterprise value between $750 million to $2500 million. The firm conducts an in-house research to create its investment portfolio. It seeks to acquire minority and majority positions in its portfolio companies. Apollo Global Management, Inc. was founded in 1990 and is headquartered in New York, New York with additional offices in North America, Asia, India and Europe. | null | 408 |
US | APOG | NMS | EQUITY | USD | Apogee Enterprises, Inc. | Industrials | Building Products & Equipment | 44.78 | 114,073 | 994,361,600 | 2023-10-17T07:48:51.740029 | Apogee Enterprises, Inc. designs and develops glass and metal products and services in the United States, Canada, and Brazil. The company operates in four segments: Architectural Framing Systems, Architectural Glass, Architectural Services, and Large-Scale Optical Technologies (LSO). The Architectural Framing Systems segment designs, engineers, fabricates, and installs custom glass and aluminum windows, curtainwalls, storefront, and entrance systems for the exterior of buildings primarily in the commercial, institutional, and multi-family residential construction sectors. The Architectural Glass segment provides a range of high-performance glass products for use in in windows, curtainwall, storefront, and entrance systems. The Architectural Services segment integrates technical services, project management, and field installation services to design, engineer, fabricate, and install building glass and curtainwall systems. The LSO segment manufactures high-performance glazing products for the custom framing, fine art, and engineered optics markets. The company's products and services are primarily used in commercial buildings, such as office buildings, hotels, and retail centers; and institutional buildings comprising education facilities, health care facilities, and government buildings, as well as multi-family residential buildings. It markets its architectural products and services through direct sales force, independent sales representatives, and distributors to glazing subcontractors and general contractors; and value-added glass and acrylics through retail chains, as well as independent distributors to museums, galleries, and other customers. The company was incorporated in 1949 and is based in Minneapolis, Minnesota. | null | 409 |
US | APP | NMS | EQUITY | USD | AppLovin Corporation | Technology | Software - Application | 38.52 | 2,238,587 | 13,525,786,624 | 2023-10-17T07:48:58.480322 | AppLovin Corporation engages in building a software-based platform for mobile app developers to enhance the marketing and monetization of their apps in the United States and internationally. The company's software solutions include AppDiscovery, a marketing software solution, which matches advertiser demand with publisher supply through auctions; Adjust, an analytics platform that helps marketers grow their mobile apps with solutions for measuring, optimizing campaigns, and protecting user data; MAX, an in-app bidding software that optimizes the value of an app's advertising inventory by running a real-time competitive auction; and Wurl, a connected TV platform, which primarily distributes streaming video for content companies. Its business clients include various advertisers, internet platforms, and others. The company was incorporated in 2011 and is headquartered in Palo Alto, California. | null | 410 |
US | APPF | NGM | EQUITY | USD | AppFolio, Inc. | Technology | Software - Application | 180.67 | 143,697 | 6,600,648,192 | 2023-10-17T07:49:04.574677 | AppFolio, Inc., together with its subsidiaries, provides cloud business management solutions for the real estate industry. The company offers AppFolio Property Manager, a platform to leverage process automation, easy to use interface, and the optimization of common workflows for property management companies, as well as completes and records critical transactions in the system and give its customers access to the data they need to run their business; AppFolio Property Manager Plus, which offers customizable workflows that allow customers to digitize their existing processes, performance insights, intelligent revenue management, and integrations through selected partners and dedicated strategic account managers; and AppFolio Investment Management, a solution that is designed to enable real estate investment management organizations to manage investor relationships through enhancing transparency and streamlining certain business processes. It also provides value added services that are designed to enhance, automate, and streamline processes and workflows for property management businesses, such as electronic payment, tenant screening, and insurance services. AppFolio, Inc. was incorporated in 2006 and is headquartered in Santa Barbara, California. | null | 411 |
US | APPH | null | null | null | null | null | null | null | null | null | null | null | error | 412 |
US | APPN | NGM | EQUITY | USD | Appian Corporation | Technology | Software - Infrastructure | 41.27 | 169,807 | 3,130,134,528 | 2023-10-17T07:49:11.371911 | Appian Corporation provides low-code process automation platform in the United States and internationally. The company's platform offers workflow, artificial intelligence, robotic process automation, data fabric, and process mining. It provides The Appian Platform, an integrated automation platform that enables organizations to design, automate, and optimize end-to-end processes and complex business operations. The company also offers professional and customer support services. It serves to financial services, government, life sciences, insurance, manufacturing, energy, healthcare, telecommunications, and transportation industries. The company was incorporated in 1999 and is headquartered in McLean, Virginia. | null | 413 |
US | APPS | NCM | EQUITY | USD | Digital Turbine, Inc. | Technology | Software - Application | 5.35 | 1,326,278 | 553,848,704 | 2023-10-17T07:49:18.321084 | Digital Turbine, Inc., through its subsidiaries, operates a mobile growth platform for advertisers, publishers, carriers, and device original equipment manufacturers (OEMs). The company operates through two segments, On Device Solutions and App Growth Platform. Its application media platform delivers mobile applications to various publishers, carriers, OEMs, and devices; and content media platform offers news, weather, sports, and other content, as well as programmatic advertising and media content delivery services, and sponsored and editorial content media. The company also provides direct campaign management products, such as the DT DSP and DT Offer Wall; ad monetization solutions allow mobile app publishers and developers to monetize their monthly active users via display, native, and video advertising; brands and agencies runs mobile brand-awareness campaigns on the direct mobile app inventory; and app developers and other performance-focused advertisers execute mobile user acquisition campaigns for their apps and products. It operates in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, China, Mexico, Central America, and South America. The company is headquartered in Austin, Texas. | null | 414 |
US | APRE | NCM | EQUITY | USD | Aprea Therapeutics, Inc. | Healthcare | Biotechnology | 5.26 | 16,218 | 19,430,684 | 2023-10-17T07:49:25.343910 | Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors, ovarian, breast, and prostate cancers. The company is also developing ATRN-1051, ATRN-354, and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania. | null | 415 |
US | APRN | NGM | EQUITY | USD | Blue Apron Holdings, Inc. | Consumer Cyclical | Internet Retail | 12.93 | 257,937 | 83,062,936 | 2023-10-17T07:49:31.001177 | Blue Apron Holdings, Inc. operates a direct-to-consumer platform that delivers original recipes with fresh and seasonal ingredients. The company also operates Blue Apron Market, an e-commerce market that provides cooking tools, utensils, pantry items, and other products. In addition, it offers Blue Apron Wine, a direct-to-consumer wine delivery service that sells wines, which can be paired with its meals. The company serves young couples, families, singles, and empty nesters. It offers its services through order selections on Website or mobile application primarily in the United States. The company was founded in 2012 and is headquartered in New York, New York. | null | 416 |
US | APT | ASE | EQUITY | USD | Alpha Pro Tech, Ltd. | Industrials | Building Products & Equipment | 4.02 | 16,636 | 48,248,464 | 2023-10-17T07:49:38.852274 | Alpha Pro Tech, Ltd., together with its subsidiaries, develops, manufactures, and markets a range of disposable protective apparel, infection control, and building supply products in the United States and internationally. The company operates through two segments, Disposable Protective Apparel and Building Supply. The Disposable Protective Apparel segment provides shoe covers, bouffant caps, coveralls, frocks, lab coats, and gowns, hoods, as well as face masks and shields. The Building Supply segment offers construction weatherization products, such as housewrap and housewrap accessories, including window and door flashing, and seam tape, and synthetic roof underlayment, as well as other woven material. The company markets its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. The company was founded in 1983 and is headquartered in Markham, Canada. | null | 417 |
US | APTM | NCM | EQUITY | USD | Alpha Partners Technology Merger Corp. | Financial Services | Shell Companies | 10.65 | 88 | 241,168,176 | 2023-10-17T07:49:46.253323 | Alpha Partners Technology Merger Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York. | null | 418 |
US | APTO | NCM | EQUITY | USD | Aptose Biosciences Inc. | Healthcare | Biotechnology | 2.14 | 151,836 | 20,512,744 | 2023-10-17T07:49:53.462461 | Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and Tuspetinib, an oral potent myeloid kinase inhibitor that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory AML. The company also develops luxeptinib, an orally administered, and potent dual lymphoid and myeloid kinome inhibitor that is in Phase 1a/b clinical trial for treating patients with relapsed or refractory B-cell malignancies, including chronic lymphocytic leukemia, small lymphocytic lymphoma, and various non-Hodgkin's lymphomas, as well as AML and HR MDS. It has agreements with CrystalGenomics, Inc. and Hanmi Pharmaceutical Co. Ltd. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada. | null | 419 |
US | APTV | NYQ | EQUITY | USD | Aptiv PLC | Consumer Cyclical | Auto Parts | 94.96 | 1,097,021 | 27,329,282,048 | 2023-10-17T07:49:59.362106 | Aptiv PLC engages in design, manufacture, and sale of vehicle components worldwide. The company provides electrical, electronic, and safety technology solutions to the automotive and commercial vehicle markets. It operates in two segments, Signal and Power Solutions, and Advanced Safety and User Experience. The Signal and Power Solutions segment designs, manufactures, and assembles vehicle's electrical architecture, including engineered component products, connectors, wiring assemblies and harnesses, cable management products, electrical centers, and hybrid high voltage and safety distribution systems. The Advanced Safety and User Experience segment provides critical technologies and services for vehicle safety, security, comfort, and convenience, such as sensing and perception systems, electronic control units, multi-domain controllers, vehicle connectivity systems, application software, autonomous driving technologies, and end-to-end DevOps tools. The company was formerly known as Delphi Automotive PLC and changed its name to Aptiv PLC in December 2017. Aptiv PLC was incorporated in 2011 and is based in Dublin, Ireland. | null | 420 |
US | APVO | NCM | EQUITY | USD | Aptevo Therapeutics Inc. | Healthcare | Biotechnology | 0.32 | 666,072 | 3,629,965 | 2023-10-17T07:50:07.708671 | Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company's lead clinical candidates are APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndromes; and. ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a tumor antigen expressed in various types of cancers. Its preclinical candidates include APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40; APVO711, a dual mechanism bispecific ADAPTIR candidate designed to provide synergistic stimulation of CD40 on antigen presenting cells; and APVO442, a bispecific candidate based on the ADAPTIR-FLEX platform technology to enhance biodistribution of drugs to PSMA positive tumors for treatment of prostate cancer. The company has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington. | null | 421 |
US | APWC | NCM | EQUITY | USD | Asia Pacific Wire & Cable Corporation Limited | Industrials | Electrical Equipment & Parts | 1.26 | 629 | 25,976,412 | 2023-10-17T07:50:15.367710 | Asia Pacific Wire & Cable Corporation Limited, through its subsidiaries, manufactures and distributes enameled wire, power cable, and telecommunications products in Thailand, Singapore, Australia, the People's Republic of China, Hong Kong, and other markets in the Asia Pacific region. The company offers copper rods; and telecommunications cable products, including copper-based and fiber optic cables for telephone and data transmissions; and armored and unarmored low voltage power transmission cable, which is used to transmit electricity to and within commercial and residential buildings, as well as to outdoor installations, such as streetlights, traffic signals, and other signs. It also provides enameled wire for use in the assembly of a range of electrical products consisting of oil-filled transformers, refrigerator motors, telephones, radios, televisions, fan motors, air conditioner compressors, and other electric appliances. In addition, the company distributes wire and cable products; and offers project engineering services in the supply, delivery, and installation of power cables, as well as fabrication services for converting raw materials to wire and cable products. It serves government organizations, electric contracting firms, electrical dealers, appliance component manufacturers, state owned entities, and wire and cable dealers and factories. The company was incorporated in 1996 and is headquartered in Taipei, Taiwan. Asia Pacific Wire & Cable Corporation Limited is a subsidiary of Pacific Electric Wire & Cable Co., Ltd. | null | 422 |
US | APXI | NGM | EQUITY | USD | APx Acquisition Corp. I | Financial Services | Shell Companies | 11.04 | 561 | 119,560,096 | 2023-10-17T07:50:21.893811 | APx Acquisition Corp. I. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. APx Acquisition Corp. I. was incorporated in 2021 and is based in Mexico City, Mexico. | null | 423 |
US | APYX | NMS | EQUITY | USD | Apyx Medical Corporation | Healthcare | Medical Devices | 2.355 | 250,453 | 87,302,624 | 2023-10-17T07:50:28.102440 | Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and laparoscopic surgical procedures. The company's Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also offers hand pieces for open and laparoscopic procedures, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida. | null | 424 |
US | AQB | NCM | EQUITY | USD | AquaBounty Technologies, Inc. | Consumer Defensive | Farm Products | 4.1 | 104,854 | 297,563,712 | 2023-10-17T07:50:34.442509 | AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. It engages in genetic, genomic, and fish health and nutrition research activities. The company also operates salmon farms using proprietary technology. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts. | null | 425 |
US | AQMS | NCM | EQUITY | USD | Aqua Metals, Inc. | Industrials | Waste Management | 0.97 | 205,831 | 104,519,648 | 2023-10-17T07:50:42.079804 | Aqua Metals, Inc. engages in the business of applying a commercialized clean water-based recycling technology to develop recycling solutions for lead and lithium-ion batteries in the United States. Its AquaRefining technology, a recycling technology that replaces polluting furnaces and hazardous chemicals with electricity-powered electroplating to recover metals and materials from spent batteries. The company also produces and sells hard lead, lead compounds, and plastics. Aqua Metals, Inc. was incorporated in 2014 and is based in Reno, Nevada. | null | 426 |
US | AQN | NYQ | EQUITY | USD | Algonquin Power & Utilities Corp. | Utilities | Utilities - Renewable | 5.74 | 3,640,712 | 3,953,786,368 | 2023-10-17T07:50:50.059124 | Algonquin Power & Utilities Corp., a renewable energy and utility company, that provides energy and water solutions and services in North America and internationally. The company operates through two segments, Regulated Services Group and Renewable Energy Group. The Regulated Services Group segment provides a portfolio of rate-regulated water, electricity, and gas utility services. It offers electricity distribution, water distribution, waste water treatment, and natural gas distribution services. The Renewable Energy Group segment generates and sells electrical energy produced by its portfolio of renewable power generation facilities primarily in the United States and Canada. It owns and operates hydroelectric, wind, solar, renewable natural gas, and thermal facilities. Algonquin Power & Utilities Corp. was incorporated in 1988 and is headquartered in Oakville, Canada. | null | 427 |
US | AQST | NGM | EQUITY | USD | Aquestive Therapeutics, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 1.54 | 299,277 | 115,438,232 | 2023-10-17T07:50:57.731784 | Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; and AQST-109, an orally delivered epinephrine product candidate for the emergency treatment of allergic reactions, including anaphylaxis. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey. | null | 428 |
US | AQU | NCM | EQUITY | USD | Aquaron Acquisition Corp. | Financial Services | Shell Companies | 10.74 | 1 | 48,354,452 | 2023-10-17T07:51:05.631917 | Aquaron Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses. It intends to focus on operating businesses in the new energy sector. The company was incorporated in 2021 and is based in New York, New York. | null | 429 |
US | AR | NYQ | EQUITY | USD | Antero Resources Corporation | Energy | Oil & Gas E&P | 27.83 | 2,903,071 | 8,347,671,552 | 2023-10-17T07:51:13.119126 | Antero Resources Corporation, an independent oil and natural gas company, engages in the development, production, exploration, and acquisition of natural gas, natural gas liquids (NGLs), and oil properties in the United States. It operates through three segments: Exploration, Development and Production of Natural Gas, NGLs and Oil; Marketing and Utilization of Excess Firm Transportation Capacity; and Midstream Services Through Our Equity Method Investment in Antero Midstream. As of December 31, 2022, the company had approximately 504,000 net acres in the Appalachian Basin; and 174,000 net acres in the Upper Devonian Shale. It also owned and operated 620 miles of gas gathering pipelines in the Appalachian Basin; and 34 compressor stations. The company was formerly known as Antero Resources Appalachian Corporation and changed its name to Antero Resources Corporation in June 2013. Antero Resources Corporation was incorporated in 2002 and is headquartered in Denver, Colorado. | null | 430 |
US | ARAV | NMS | EQUITY | USD | Aravive, Inc. | Healthcare | Biotechnology | 0.148 | 4,015,679 | 10,041,295 | 2023-10-17T07:51:20.072771 | Aravive, Inc., a clinical-stage biopharmaceutical company, develops transformative treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of platinum- resistant recurrent ovarian cancer; and in Phase Ib/II clinical trial for the treatment of clear cell renal cell carcinoma and pancreatic adenocarcinoma. The company also develops AVB-S6, a soluble Fc-fusion protein to block the activation of the GAS6-AXL signaling pathway. It has a license and collaboration agreement with WuXi Biologics (Hong Kong) Limited to identify and develop novel high-affinity bispecific antibodies targeting cancer and fibrosis; and license agreement with 3D Medicines Inc. to develop products that contain batiraxcept as the sole drug substance for the treatment of human oncological diseases in mainland China, Taiwan, Hong Kong, and Macau. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. was incorporated in 2008 and is headquartered in Houston, Texas. | null | 431 |
US | ARAY | NMS | EQUITY | USD | Accuray Incorporated | Healthcare | Medical Devices | 2.84 | 238,477 | 278,179,200 | 2023-10-17T07:51:25.848012 | Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin. | null | 432 |
US | ARBB | NCM | EQUITY | USD | ARB IOT Group Limited | Technology | Information Technology Services | 1.51 | 12,853 | 38,135,000 | 2023-10-17T07:51:33.862570 | ARB IOT Group Limited, through its subsidiaries, provides Internet of Things (IoT) system solutions, and system integration and support services. It also offers IoT smart home and building solutions, such as design, procurement, and provision of smart home products and devices; integration services; and electrical wire installation and home data network setup for homeowners, as well as provides smart building solutions, including design, procurement, installation, testing, pre-commissioning and commissioning of various IoT systems, solutions, and devices; and integration of automated systems for smart buildings, including installation of wire and wireless, and mechatronic works for property developers and contractors. In addition, the company offers IoT smart agriculture solutions, such as supply, installation, commissioning, and testing of smart hydroponic system; IoT system development solutions, including procure, supply, and deliver industrial building systems for construction projects; and IoT gadget distribution solutions, such as mobile gadget accessories, as well as provides shipping tracking and status updates, customer care line, online chat support, digital marketing, pre-installation, and warranty services. The company was incorporated in 2022 and is based in Kuala Lumpur, Malaysia. ARB IOT Group Limited operates as a subsidiary of ARB IOT Limited | null | 433 |
US | ARBE | NCM | EQUITY | USD | Arbe Robotics Ltd. | Technology | Software - Infrastructure | 2.16 | 28,142 | 165,083,328 | 2023-10-17T07:51:40.306588 | Arbe Robotics Ltd., a semiconductor company, provides 4D imaging radar solutions for tier 1 automotive suppliers and automotive manufacturers in China, Sweden, Germany, Switzerland, the United States, Italy, and Israel. It offers 4D imaging radar chipset solutions that address the core issues that have caused autonomous vehicle and autopilot accidents, such as detecting stationary objects, identifying vulnerable road users, operation at poor lighting conditions, and eliminating false alarms without radar ambiguities. The company was founded in 2015 and is headquartered in Tel Aviv-Yafo, Israel. | null | 434 |
US | ARBG | null | null | null | null | null | null | null | null | null | null | null | error | 435 |
US | ARBK | NMS | EQUITY | USD | Argo Blockchain plc | Financial Services | Capital Markets | 1.03 | 192,886 | 55,673,796 | 2023-10-17T07:51:47.944510 | Argo Blockchain plc, together with its subsidiaries, engages in the bitcoin and other cryptocurrencies mining business worldwide. It engages in mining purpose-built computers for complex cryptographic algorithms. The company was formerly known as GoSun Blockchain Limited and changed its name to Argo Blockchain plc in December 2017. Argo Blockchain plc was incorporated in 2017 and is based in London, the United Kingdom. | null | 436 |
US | ARC | NYQ | EQUITY | USD | ARC Document Solutions, Inc. | Industrials | Specialty Business Services | 2.93 | 250,863 | 132,296,648 | 2023-10-17T07:51:53.953183 | ARC Document Solutions, Inc., a digital printing company, provides digital printing and document-related services in the United States. It provides managed print services, that places, manages, and optimizes print and imaging equipment in customers' offices, job sites, and other facilities; and cloud-based document management software and other digital hosting services. The company also provides professional services and software services to re-produce and distribute large-format and small-format documents, and specialized graphic color printing. In addition, it engages in sale and supply of equipment; and provides ancillary services. The company operates service centers in the United States, Canada, China, United Kingdom, India, United Arab Emirates. It serves local restaurant owners, construction subcontractors, international retailers, regional energy companies, and largest school districts, as well as retail, technology, energy, education, hospitality, public utilities, and others. The company was formerly known as American Reprographics Company and changed its name to ARC Document Solutions, Inc. in 2012. ARC Document Solutions, Inc. was founded in 1988 is headquartered in San Ramon, California. | null | 437 |
US | ARCB | NMS | EQUITY | USD | ArcBest Corporation | Industrials | Trucking | 95.9 | 175,944 | 2,380,877,568 | 2023-10-17T07:52:00.260074 | ArcBest Corporation provides freight transportation and integrated logistics services. It operates through three segments: Asset-Based, ArcBest, and FleetNet. The Asset-Based segment transports general commodities, such as food, textiles, apparel, furniture, appliances, chemicals, nonbulk petroleum products, rubber, plastics, metal and metal products, wood, glass, automotive parts, machinery, and miscellaneous manufactured products through less-than-truckload services. It also offers motor carrier freight transportation services to customers in Mexico through arrangements with trucking companies. The ArcBest segment provides expedite freight transportation services to commercial and government customers; premium logistics services, such as deployment of specialized equipment to meet linehaul requirements; and international freight transportation with air, ocean, and ground services. It also offers third-party transportation brokerage services by sourcing various capacity solutions, including dry van over-the-road, temperature-controlled and refrigerated, flatbed, intermodal or container shipping, and specialized equipment; full-container and less-than-container load ocean transportation services; warehousing and distribution services; managed transportation services; and moving services to do-it-yourself' consumer, as well as provides final mile, time critical, product launch, retail logistics, supply chain optimization, and trade show shipping services. The FleetNet segment provides roadside repair solutions and vehicle maintenance management services for commercial and private fleets through a network of third-party service providers. The company was formerly known as Arkansas Best Corporation and changed its name to ArcBest Corporation in May 2014. ArcBest Corporation was founded in 1923 and is headquartered in Fort Smith, Arkansas. | null | 438 |
US | ARCC | NGM | EQUITY | USD | Ares Capital Corporation | Financial Services | Asset Management | 19.03 | 2,907,490 | 10,857,742,336 | 2023-10-17T07:52:08.274922 | Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies. | null | 439 |
US | ARCE | NMS | EQUITY | USD | Arco Platform Limited | Consumer Defensive | Education & Training Services | 13.81 | 27,433 | 916,820,160 | 2023-10-17T07:52:16.792341 | Arco Platform Limited, a technology company in the education sector, provides a pedagogical system with technology-enabled features to deliver educational content to private schools in Brazil. The company's curriculum solutions provide educational content from basic to secondary education K-12 curriculum in printed and digital formats delivered through its platform. The company's activities also comprise editing, publishing, advertising, and sale of educational content for private schools. It serves students, teachers, administrators, and parents. Arco Platform Limited was founded in 1941 and is headquartered in Sao Paulo, Brazil. | null | 440 |
US | ARCH | NYQ | EQUITY | USD | Arch Resources, Inc. | Basic Materials | Coking Coal | 154.48 | 373,264 | 2,807,421,440 | 2023-10-17T07:52:24.656663 | Arch Resources, Inc. produces and sells metallurgical products. As of December 31, 2022, the company operated seven active mines. It also owned or controlled primarily through long-term leases approximately 28,292 acres of coal land in Ohio; 952 acres of coal land in Maryland; 10,095 acres of coal land in Virginia; 306,263 acres of coal land in West Virginia; 81,450 acres of coal land in Wyoming; 234,087 acres of coal land in Illinois; 33,047 acres of coal land in Kentucky; 362 acres of coal land in Montana; 248 acres of coal land in Pennsylvania; and 19,018 acres of coal land in Colorado, as well as smaller parcels of property in Alabama, Indiana, Washington, Arkansas, California, Utah, and Texas. The company sells its products to utility, industrial, and steel producers in the United States and internationally. Arch Resources, Inc. was incorporated in 1969 and is headquartered in St. Louis, Missouri. | null | 441 |
US | ARCO | NYQ | EQUITY | USD | Arcos Dorados Holdings Inc. | Consumer Cyclical | Restaurants | 9.45 | 698,675 | 2,053,886,336 | 2023-10-17T07:52:31.489970 | Arcos Dorados Holdings Inc. operates as a franchisee of McDonald's restaurants. It has the exclusive right to own, operate, and grant franchises of McDonald's restaurants in 20 countries and territories in Latin America and the Caribbean, including Argentina, Aruba, Brazil, Chile, Colombia, Costa Rica, Curacao, Ecuador, French Guiana, Guadeloupe, Martinique, Mexico, Panama, Peru, Puerto Rico, Trinidad and Tobago, Uruguay, the U.S. Virgin Islands of St. Croix and St. Thomas, and Venezuela. The company was founded in 2007 and is based in Montevideo, Uruguay. | null | 442 |
US | ARCT | NGM | EQUITY | USD | Arcturus Therapeutics Holdings Inc. | Healthcare | Biotechnology | 22.92 | 344,447 | 602,721,984 | 2023-10-17T07:52:37.406842 | Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. The company was founded in 2013 and is headquartered in San Diego, California. | null | 443 |
US | ARDC | NYQ | EQUITY | USD | Ares Dynamic Credit Allocation Fund, Inc. | Financial Services | Asset Management | 12.55 | 182,387 | 289,645,600 | 2023-10-17T07:52:43.800508 | Ares Dynamic Credit Allocation Fund, Inc. is a closed-ended fixed income fund launched by Ares Management LLC. The fund is managed by Ares Capital Management II LLC. It primarily invests in the U.S. securities and companies. The fund primarily invests in debt instruments such as senior loans made primarily to companies whose debt is rated below investment grade, corporate bonds that are primarily high yield issues rated below investment grade, equity securities of CLOs and debt securities issued by CLOs, and other fixed-income instruments. It focuses on such factors as the overall macroeconomic environment, financial markets, and company specific research and analysis, to create its portfolio. Ares Dynamic Credit Allocation Fund, Inc. was formed on November 27, 2012 and is domiciled in the United States.. | null | 444 |
US | ARDS | PNK | EQUITY | USD | Aridis Pharmaceuticals, Inc. | Healthcare | Biotechnology | 0.0935 | 61,861 | 3,381,997 | 2023-10-17T07:52:50.681793 | Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, discovers and develops targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that has completed Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin, as well as developing AR-301 as an adjunctive therapy with SOC antibiotics to treat hospital acquired pneumonia and ventilator associated pneumonia. The company is also developing AR-320, a fully human IgG1 monoclonal antibody targeting S. aureus alpha toxin to treat infections caused by methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus; AR 501, an inhaled gallium citrate, which is in Phase 1/2a for the treatment of chronic lung infection associated with cystic fibrosis; and AR-101, a human IgM mAb, which is in Phase II clinical trials targeting Pseudomonas aeruginosa liposaccharides serotype O11. In addition, it develops AR-401 that is in preclinical stage to treat infections caused by Acinetobacter baumannii; AR-201, a fully human IgG1 mAb preclinical program for respiratory syncytial virus; and AR-701, a cocktail of two fully human immunoglobulin 1. The company was founded in 2003 and is headquartered in Los Gatos, California. | null | 445 |
US | ARDX | NGM | EQUITY | USD | Ardelyx, Inc. | Healthcare | Biotechnology | 3.33 | 6,206,001 | 755,984,640 | 2023-10-17T07:52:57.105208 | Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation. It also develops XPHOZAH, which is in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia; RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, for adult patients with metabolic acidosis, a serious electrolyte disorder. The company has agreements with Kyowa Kirin, Fosun Pharmaceutical Industrial Development Co. Ltd., and Knight Therapeutics, Inc. for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts. | null | 446 |
US | ARE | NYQ | EQUITY | USD | Alexandria Real Estate Equities, Inc. | Real Estate | REIT - Office | 98.88 | 1,177,831 | 17,458,526,208 | 2023-10-17T07:53:04.639378 | Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since its founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The trusted partner to approximately 825 tenants, Alexandria has a total market capitalization of $30.6 billion and an asset base in North America of 74.9 million SF as of June 30, 2023, which includes 41.1 million RSF of operating properties and 5.3 million RSF of Class A/A+ properties undergoing construction, 9.4 million RSF of near-term and intermediate-term development and redevelopment projects, and 19.1 million SF of future development projects. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in life science, agtech, and advanced technology campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, agrifoodtech, climate innovation, and technology companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. | null | 447 |
US | AREB | NCM | EQUITY | USD | American Rebel Holdings, Inc. | Consumer Cyclical | Footwear & Accessories | 0.5499 | 94,416 | 2,332,670 | 2023-10-17T07:53:12.314110 | American Rebel Holdings, Inc. designs and markets branded safes, and personal security and self-defense products. The company offers home, office, and personal safes, as well as vault doors; concealed carry backpacks; and a range of concealed carry jackets, vests, coats, and T-shirts for men and women. It also provides accessories, such as back-over and back-under handgun hangers, ballistic shields, safe light kits, mag minders, moisture guards, and rifle rod kits and rods. The company markets its products through regional retailers; and specialty safe, sporting goods, hunting, and firearms stores, as well as online through own website and e-commerce platforms. American Rebel Holdings, Inc. was incorporated in 2014 and is based in Nashville, Kansas. | null | 448 |
US | AREC | NCM | EQUITY | USD | American Resources Corporation | Basic Materials | Coking Coal | 1.62 | 129,257 | 125,923,744 | 2023-10-17T07:53:17.888953 | American Resources Corporation engages in the extraction, processing, transportation, distribution, and sale of metallurgical coal to the steel industries. The company supplies raw materials; and sells coal used in pulverized coal injections. It has a portfolio of operations located in the Pike, Knott, and Letcher Counties in Kentucky; and Wyoming County, West Virginia. The company was founded in 2006 and is headquartered in Fishers, Indiana. | null | 449 |
US | AREN | ASE | EQUITY | USD | The Arena Group Holdings, Inc. | Communication Services | Internet Content & Information | 4.32 | 16,557 | 98,256,416 | 2023-10-17T07:53:24.915325 | The Arena Group Holdings, Inc., together with its subsidiaries, operates digital media platform the United States and internationally. The company offers the Platform, a proprietary online publishing platform comprising publishing tools, video platforms, social distribution channels, newsletter technology, machine learning content recommendations, notifications, and other technology. It operates the media businesses for Sports Illustrated brand; and owns and operates TheStreet, The Spun, Parade, and Men's Journal brands. The company was formerly known as TheMaven, Inc. and changed its name to The Arena Group Holdings, Inc. in February 2022. The company is based in New York, New York. The Arena Group Holdings, Inc. operates as a subsidiary of Authentic Brands Group Inc. | null | 450 |
US | ARES | NYQ | EQUITY | USD | Ares Management Corporation | Financial Services | Asset Management | 108.53 | 727,128 | 33,509,380,096 | 2023-10-17T07:53:33.170237 | Ares Management Corporation operates as an alternative asset manager in the United States, Europe, and Asia. The company's Tradable Credit Group segment manages various types of investment funds, such as commingled and separately managed accounts for institutional investors, and publicly traded vehicles and sub-advised funds for retail investors in the tradable and non-investment grade corporate credit markets. Its Direct Lending Group segment provides financing solutions to small-to-medium sized companies. The company's Private Equity Group segment focuses on majority or shared-control investments primarily in under-capitalized companies. Its Real Estate Group segment invests in new developments and the repositioning of assets, with a focus on control or majority-control investments; and originates and invests in a range of self-originated financing opportunities for middle-market owners and operators of commercial real estate. The firm was previously known as Ares Management, L.P. Ares Management Corporation was founded in 1997 and is headquartered in Los Angeles, California with additional offices in the United States, Europe and Asia. Ares Management GP LLC is the general partner of the company. | null | 451 |
US | ARGO | NYQ | EQUITY | USD | Argo Group International Holdings, Ltd. | Financial Services | Insurance - Property & Casualty | 29.72 | 199,080 | 1,049,613,312 | 2023-10-17T07:53:39.538193 | Argo Group International Holdings, Ltd. underwrites specialty insurance and reinsurance products in the property and casualty markets. The company operates in two segments, U.S. Operations and International Operations. It offers primary and excess specialty casualty, general liability, commercial multi-peril, and workers compensation, as well as product, environmental, and auto liability insurance products; management liability, transaction liability, and errors and omissions liability insurance; primary and excess property, inland marine, and auto physical damage insurance; and surety, animal mortality, and ocean marine insurance products. The company also provides directors and officers liability, errors and omissions liability, and employment practices liability insurance; international casualty and motor treaties insurance; professional indemnity and medical malpractice insurance; direct and facultative excess insurance, North American and international binders, and residential collateral protection for lending institutions; and personal accident, aviation, cargo, yachts, and onshore and offshore marine insurance products. It markets its products through wholesale and retail agents, managing general agents, brokers, and third-party intermediaries. The company was founded in 1948 and is headquartered in Pembroke, Bermuda. | null | 452 |
US | ARGT | PCX | ETF | USD | Global X MSCI Argentina ETF | null | null | 40.505 | 13,488 | 61,866,392 | 2023-10-17T07:53:47.886928 | The fund invests at least 80% of its total assets in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is designed to represent the performance of the broad Argentina equity universe, while including a minimum number of constituents. The fund is non-diversified. | null | 453 |
US | ARGX | NMS | EQUITY | USD | argenx SE | Healthcare | Biotechnology | 493.48 | 100,927 | 29,938,941,952 | 2023-10-17T07:53:54.815713 | argenx SE, a biotechnology company, engages in the developing of various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany, France, Canada, the United Kingdom, and Italy. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, pemphigus foliaceus, chronic inflammatory demyelinating polyneuropathy, bullous pemphigoid, and idiopathic inflammatory myopathy; and ENHANZE SC. The company is also developing ARGX-109 and ARGX-116; ARGX-117 for severe autoimmune indications; ARGX-118 for airway inflammation; ARGX-119, an antibody that targets muscle-specific tyrosine kinase stage; and ARGX-114, an antibody directed against the mesenchymal-epithelial transition factor receptor. In addition, its partnered product candidates include Cusatuzumab for treatment of acute myeloid leukemia; ARGX-115 for the treatment of cancer; and ARGX-112 to treat interleukin-22 receptor. The company has strategic partnership with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S; and collaboration and license agreement with Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Staten Biotechnology B.V., and Shire International GmbH. It also has collaboration agreement with Genmab A/S to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology, as well as a strategic collaboration with IQVIA Holdings Inc. to provide safety systems and services. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands. | null | 454 |
US | ARHS | NMS | EQUITY | USD | Arhaus, Inc. | Consumer Cyclical | Home Improvement Retail | 9.45 | 383,477 | 1,362,138,240 | 2023-10-17T07:54:02.496796 | Arhaus, Inc. operates as a lifestyle brand and premium retailer in the home furnishings market. It provides merchandise assortments across various categories, including furniture, lighting, textiles, décor, and outdoor. The company's furniture products comprise bedroom, dining room, living room, and home office furnishings, which includes sofas, dining tables and chairs, accent chairs, console and coffee tables, beds, headboards, dressers, desks, bookcases, modular storage, etc.; and outdoor products, such as outdoor dining tables, chairs, chaises and other furniture, lighting, textiles, décor, umbrellas, and fire pits. In addition, it offers lighting products, including various distinct and artistic lighting fixtures comprising chandeliers, pendants, table and floor lamps, and sconces; textile products, such as handcrafted indoor and outdoor rugs, bed linens, and pillows and throws; and décor products, including various wall art to mirrors, vases to candles, and other decorative accessories. The company distributes its products through an omni-channel model comprising showrooms, e-commerce platform, print and digital media, and in-home designer services. Arhaus, Inc. was founded in 1986 and is headquartered in Boston Heights, Ohio. | null | 455 |
US | ARI | NYQ | EQUITY | USD | Apollo Commercial Real Estate Finance, Inc. | Real Estate | REIT - Mortgage | 10.09 | 1,070,324 | 1,441,800,448 | 2023-10-17T07:54:08.905249 | Apollo Commercial Real Estate Finance, Inc. operates as a real estate investment trust (REIT) that originates, acquires, invests in, and manages commercial first mortgage loans, subordinate financings, and other commercial real estate-related debt investments in the United States. It is qualified as a REIT under the Internal Revenue Code. As a REIT, it would not be subject to federal income taxes, if the company distributes at least 90% of its REIT taxable income to its stockholders. Apollo Commercial Real Estate Finance, Inc. was founded in 2009 and is based in New York, New York. | null | 456 |
US | ARIS | NYQ | EQUITY | USD | Aris Water Solutions, Inc. | Utilities | Utilities - Regulated Water | 9.1 | 372,210 | 543,433,920 | 2023-10-17T07:54:14.977446 | Aris Water Solutions, Inc., an environmental infrastructure and solutions company, provides water handling and recycling solutions. Its produced water handling business gathers, transports, unless recycled, and handles produced water generated from oil and natural gas production. The company's water solutions business develops and operates recycling facilities to treat, store, and recycle produced water. Aris Water Solutions, Inc. was founded in 2015 and is headquartered in Houston, Texas. | null | 457 |
US | ARIZ | NGM | EQUITY | USD | Arisz Acquisition Corp. | Financial Services | Shell Companies | 10.72 | 0 | 55,269,640 | 2023-10-17T07:54:22.978177 | Arisz Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to pursue targets in the healthcare industry in North America, Europe, and Asia. The company was incorporated in 2021 and is based in New York, New York. | null | 458 |
US | ARKG | BTS | ETF | USD | ARK Genomic Revolution ETF | null | null | 25.12 | 1,465,187 | 1,753,587,456 | 2023-10-17T07:54:29.816921 | The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified. | null | 459 |
US | ARKK | PCX | ETF | USD | ARK Innovation ETF | null | null | 37.77 | 13,612,364 | 6,878,648,320 | 2023-10-17T07:54:37.387037 | The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund's investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The fund may invest in foreign securities listed on foreign exchanges as well as American Depositary Receipts (“ADRs”) and Global Depositary Receipts (“GDRs”). The fund is non-diversified. | null | 460 |
US | ARKO | NCM | EQUITY | USD | Arko Corp. | Consumer Cyclical | Specialty Retail | 7.61 | 211,673 | 923,151,488 | 2023-10-17T07:54:44.500182 | Arko Corp. operates convenience stores in the United States. It operates through Retail, Wholesale, Fleet Fueling, and GPM Petroleum segments. The Retail segment engages in the sale of fuel and merchandise to retail consumers. Its Wholesale segment supplies fuel to third-party dealers and consignment agents. The Fleet Fueling segment supplies fuel to proprietary and third-party cardlock, and issuance of proprietary fuel cards. Its GPM Petroleum segment supplies fuel to retail and wholesale segments. The company is based in Richmond, Virginia. | null | 461 |
US | ARKQ | BTS | ETF | USD | ARK Autonomous Technology & Robotics ETF | null | null | 51.24 | 39,330 | 1,005,186,304 | 2023-10-17T07:54:51.548659 | The fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of autonomous technology and robotics companies that are relevant to the fund's investment theme of disruptive innovation. Substantially all of the fund's assets will be invested in equity securities, including common stocks, partnership interests, business trust shares and other equity investments or ownership interests in business enterprises. The fund is non-diversified. | null | 462 |
US | ARKR | NGM | EQUITY | USD | Ark Restaurants Corp. | Consumer Cyclical | Restaurants | 15.15 | 845 | 55,468,024 | 2023-10-17T07:54:58.801267 | Ark Restaurants Corp., through its subsidiaries, owns and operates restaurants and bars in the United States. It operates in New York City; Washington, D.C.; Las Vegas, Nevada; Atlantic City, New Jersey; Florida; and Alabama, as well as fast food concepts and catering operations. The company was incorporated in 1983 and is based in New York, New York. | null | 463 |
US | ARKW | PCX | ETF | USD | ARK Next Generation Internet ETF | null | null | 52.64 | 426,586 | 1,260,351,488 | 2023-10-17T07:55:05.378832 | The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund's investment theme of next generation internet. Under normal circumstances, substantially all of the fund's assets will be invested in equity securities, including common stocks, partnership interests, business trust shares and other equity investments or ownership interests in business enterprises. The fund is non-diversified. | null | 464 |
US | ARL | NYQ | EQUITY | USD | American Realty Investors, Inc. | Real Estate | Real Estate - Development | 14.7 | 3,439 | 236,626,800 | 2023-10-17T07:55:11.943538 | American Realty Investors, Inc., together with its subsidiaries, acquires, develops, and owns multifamily apartment communities and commercial real estate properties in the southwestern, southeastern, and mid-western United States. The company leases apartment units to residents; and leases office, industrial, and retail space to various for-profit businesses, as well as local, state, and federal agencies; and sells land and properties. As of December 31, 2021, its portfolio included five commercial properties comprising four office buildings and one retail properties; nine multifamily apartment communities consisting of 1,492 units; and fifty-two multifamily apartment communities totaling 10,281 units. The company also owns or controls 1,886 acres of developed and undeveloped land. American Realty Investors, Inc. was founded in 1999 and is headquartered in Dallas, Texas. | null | 465 |
US | ARLO | NYQ | EQUITY | USD | Arlo Technologies, Inc. | Industrials | Building Products & Equipment | 8.44 | 891,111 | 847,434,624 | 2023-10-17T07:55:19.184191 | Arlo Technologies, Inc., together with its subsidiaries, provides a cloud-based platform in the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions. It combines an intelligent cloud infrastructure and mobile app with various smart connected devices. The company offers Arlo Home Security System, an all-in-one multi-sensor that provides access to security experts for monitoring and responding to emergency situations; Arlo Pro 5S, a pro 5S 2K security camera; Arlo Go 2, a camera for monitoring remote areas, large properties, construction sites, vacation homes, boat or RV slips, and hard-to-access areas; Arlo Video Doorbell delivers direct-to-mobile video calls and personalized alerts; Arlo Floodlight Camera, a wire-free floodlight camera; Arlo Ultra 2; Arlo Essential XL spotlight camera for stand-alone home security; Arlo Essential Video Doorbell that enables users to see packages on the ground or visitors from head-to-toe on their mobile devices; Arlo Pro 4 camera; and Arlo Essential indoor camera; Arlo Go 2 LTE/Wi-Fi security camera. It also provides charging accessories and mounts; Arlo Secure subscriptions, including emergency response, 2K and 4K secure plus plans cloud-based video recording, unlimited cameras, advanced object detection, smart interactive notifications, smoke and CO alarm detection, cloud-based activity zones, call a friend, and 24/7 priority support and professional monitoring services; Arlo Safe app, personal safety app that offers one-touch emergency response, family safety, and crash detection and response services; and Arlo SmartCloud, a SaaS solution that delivers security cloud services for business. The company offers its products through retailers, wholesale distributors, broadcast channels, wireless carriers, and security solution providers, as well as through its website. Arlo Technologies, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California. | null | 466 |
US | ARLP | NMS | EQUITY | USD | Alliance Resource Partners, L.P. | Energy | Thermal Coal | 23.1 | 293,594 | 2,989,980,160 | 2023-10-17T07:55:26.375608 | Alliance Resource Partners, L.P., a diversified natural resource company, produces and markets coal primarily to utilities and industrial users in the United States. The company operates through four segments: Illinois Basin Coal Operations, Appalachia Coal Operations, Oil & Gas Royalties, and Coal Royalties. It produces a range of thermal and metallurgical coal with sulfur and heat contents. The company operates seven underground mining complexes in Illinois, Indiana, Kentucky, Maryland, Pennsylvania, and West Virginia. In addition, it leases land and operates a coal loading terminal on the Ohio River at Mt. Vernon, Indiana; and buys and resells coal, as well as owns mineral and royalty interests in approximately 1.5 million gross acres of oil and gas producing regions primarily in the Permian, Anadarko, and Williston Basins. Further, the company offers various mining technology products and services, including data network, communication and tracking systems, mining proximity detection systems, industrial collision avoidance systems, and data and analytics software. As of December 31, 2021, it had approximately 547.1 million tons of proven and probable coal mineral reserves, as well as 1.17 billion tons of measured, indicated, and inferred coal mineral resources in Illinois, Indiana, Kentucky, Maryland, Pennsylvania, and West Virginia. The company was founded in 1971 and is headquartered in Tulsa, Oklahoma. | null | 467 |
US | ARM | NMS | EQUITY | USD | Arm Holdings plc | Technology | Semiconductors | 50.78 | 3,312,739 | 53,448,507,392 | 2023-10-17T07:55:34.756063 | Arm Holdings plc architects, develops, and licenses central processing unit products and related technologies for semiconductor companies and original equipment manufacturers rely on to develop products. It offers microprocessors, systems intellectual property (IPs), graphics processing units, physical IP and associated systems IPs, software, tools, and other related services. Its products are used in various markets, such as automotive, computing infrastructure, consumer technologies, and Internet of things. The company operates in the United States, the People's Republic of China, Taiwan, South Korea, and internationally. The company was founded in 1990 and is headquartered in Cambridge, the United Kingdom. Arm Holdings plc operates as a subsidiary of Kronos II LLC. | null | 468 |
US | ARMK | NYQ | EQUITY | USD | Aramark | Industrials | Specialty Business Services | 25.35 | 3,740,313 | 6,941,319,680 | 2023-10-17T07:55:41.131049 | Aramark provides food, facilities, and uniform services to education, healthcare, business and industry, sports, leisure, and corrections clients in the United States and internationally. It operates through three segments: Food and Support Services United States, Food and Support Services International, and Uniform and Career Apparel. The company offers food-related managed services, including dining, catering, food service management, and convenience-oriented retail services; non-clinical support services, such as patient food and nutrition, retail food, and procurement services; and plant operations and maintenance, custodial/housekeeping, energy management, grounds keeping, and capital project management services. It also provides on-site restaurants, catering, convenience stores, and executive dining services; beverage and vending services; and facility management services comprising landscaping, transportation, payment, and other facility consulting services relating to building operations. In addition, the company offers concessions, banquet, and catering services; retail services and merchandise sale, recreational, and lodging services; and facility management services at sports, entertainment, and recreational facilities. Further, the company offers correctional food; and operates commissaries, laundry facilities, and property rooms. Additionally, it provides design, sourcing and manufacturing, delivery, cleaning, maintenance, and marketing services for uniforms and accessories; provides managed restroom services; work clothing, outerwear, and item related services that include mats, towels, linens, and first aid supplies. The company was formerly known as ARAMARK Holdings Corporation. Aramark was founded in 1959 and is based in Philadelphia, Pennsylvania. | null | 469 |
US | ARMP | ASE | EQUITY | USD | Armata Pharmaceuticals, Inc. | Healthcare | Biotechnology | 2.06 | 44,905 | 74,783,512 | 2023-10-17T07:55:47.278973 | Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California. | null | 470 |
US | ARNC | NYQ | EQUITY | USD | Arconic Corporation | Industrials | Metal Fabrication | 29.98 | 4,356,209 | 3,009,376,512 | 2023-10-17T07:55:55.489691 | Arconic Corporation manufactures and sells fabricated aluminum sheets, plates, extrusions, and architectural products and systems in the United States and internationally. It operates through three segments: Rolled Products, Building and Construction Systems, and Extrusions. The Rolled Products segment provides a range of aluminum sheet and plate products for aerospace, ground transportation, packaging, building and construction, and industrial products; and roofing, architectural composite panels, ventilated facades and ceiling panels, spacers, culvert pipes, and gutters for building and construction markets. The Building and Construction Systems segment provides various products and building envelope solutions, such as entrances, curtain walls, windows, composite panels, and coil coated sheets for fabricators and glazing subcontractors under the Kawneer, Reynobond, and Reynolux brands. The Extrusions segment offers extruded products, such as automotive shapes, aerospace shapes, seamless tubes, hollows, mortar fins, and high strength rods and bars for ground transportation, aerospace, and industrial markets. The company offers its products directly to customers, as well as through distributors. The company was formerly known as Arconic Rolled Products Corporation and changed its name to Arconic Corporation in April 2020. Arconic Corporation was founded in 1888 and is headquartered in Pittsburgh, Pennsylvania. As of August 18, 2023, Arconic Corporation was taken private. | null | 471 |
US | AROC | NYQ | EQUITY | USD | Archrock, Inc. | Energy | Oil & Gas Equipment & Services | 12.95 | 640,211 | 2,028,240,000 | 2023-10-17T07:56:01.504312 | Archrock, Inc., together with its subsidiaries, operates as an energy infrastructure company in the United States. It operates in two segments, Contract Operations and Aftermarket Services. The company engages in the designing, sourcing, owning, installing, operating, servicing, repairing, and maintaining its owned fleet of natural gas compression equipment to provide natural gas compression services to customers in the oil and natural gas industry. It also offers various aftermarket services, such as sale of parts and components; and provision of operation, maintenance, overhaul, and reconfiguration services to customers who own compression equipment. The company was formerly known as Exterran Holdings, Inc. and changed its name to Archrock, Inc. in November 2015. The company was founded in 1990 and is headquartered in Houston, Texas. | null | 472 |
US | AROW | NMS | EQUITY | USD | Arrow Financial Corporation | Financial Services | Banks - Regional | 17.85 | 48,894 | 309,961,728 | 2023-10-17T07:56:08.244691 | Arrow Financial Corporation, a bank holding company, provides commercial and consumer banking, and financial products and services. The company's deposit products include demand deposits, interest-bearing checking accounts, savings deposits, time deposits, and other time deposits. Its lending activities comprise commercial loans, such as term loans, time notes, and lines of credit; and commercial real estate loans to finance real estate purchases, refinancing, expansions, and improvements to commercial properties, as well as commercial construction and land development loans to finance projects. The company's lending activities also include consumer installment loans to finance personal expenditures, personal lines of credit, overdraft protection, and automobile loans; and residential real estate loans, fixed home equity loans, and home equity lines of credit for consumers to finance home improvements, debt consolidation, education, and other uses. In addition, it maintains an indirect lending program; and sells residential real estate loan originations into the secondary market. Further, the company provides retirement planning, trust, and estate administration services for individuals, as well as pension, profit-sharing, and employee benefit plan administration services for corporations. Additionally, it offers insurance agency services comprising group health care policies and life insurance, and property and casualty insurance products; and investment advisory services to its proprietary mutual funds, as well as holds a real estate investment trust. It operates in the northeastern region of New York State in Warren, Washington, Saratoga, Essex, Clinton, Rensselaer, Albany, and Schenectady counties, as well as surrounding areas. Arrow Financial Corporation was founded in 1851 and is headquartered in Glens Falls, New York. | null | 473 |
US | ARQQ | NCM | EQUITY | USD | Arqit Quantum Inc. | Technology | Software - Infrastructure | 0.5301 | 442,290 | 91,684,448 | 2023-10-17T07:56:14.882817 | Arqit Quantum Inc. provides cybersecurity services through satellite and terrestrial platforms in the United Kingdom. It offers QuantumCloud, a Platform as a Service that creates unbreakable software encryption keys. The company also provides maintenance and support, and professional services. Arqit Quantum Inc. is based in London, the United Kingdom. | null | 474 |
US | ARQT | NMS | EQUITY | USD | Arcutis Biotherapeutics, Inc. | Healthcare | Biotechnology | 3.88 | 1,170,081 | 231,510,784 | 2023-10-17T07:56:22.087632 | Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical formulation of ivarmacitinib designed to reach deeper into the skin in order to treat alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California. | null | 475 |
US | ARR | NYQ | EQUITY | USD | ARMOUR Residential REIT, Inc. | Real Estate | REIT - Mortgage | 18.19 | 1,504,849 | 852,584,512 | 2023-10-17T07:56:29.830464 | ARMOUR Residential REIT, Inc. invests in residential mortgage-backed securities (MBS) in the United States. The company's securities portfolio primarily consists of the United States Government-sponsored entity's (GSE) and the Government National Mortgage Administration's issued or guaranteed securities backed by fixed rate, hybrid adjustable rate, and adjustable-rate home loans, as well as unsecured notes and bonds issued by the GSE and the United States treasuries, as well as money market instruments. It also invests in other securities backed by residential mortgages for which the payment of principal and interest is not guaranteed by a GSE or government agency. The company has elected to be taxed as a real estate investment trust under the Internal Revenue Code. As a result, it would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders. The company was incorporated in 2008 and is based in Vero Beach, Florida. | null | 476 |
US | ARRW | NCM | EQUITY | USD | Arrowroot Acquisition Corp. | Financial Services | Shell Companies | 10.48 | 2,260 | 121,916,976 | 2023-10-17T07:56:35.489800 | Arrowroot Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to identify and acquire a business focusing on the enterprise software sector. Arrowroot Acquisition Corp. was incorporated in 2020 and is based in Marina Del Rey, California. | null | 477 |
US | ARRY | NGM | EQUITY | USD | Array Technologies, Inc. | Technology | Solar | 19.44 | 7,651,686 | 2,820,476,928 | 2023-10-17T07:56:43.614958 | Array Technologies, Inc. manufactures and sells ground-mounting tracking systems used in solar energy projects in the United States, Spain, Brazil, Australia, and internationally. The company operates in two segments, Array Legacy Operations and STI Operations. Its products include DuraTrack HZ v3, a single axis tracker; Array STI H250 to deliver a lower levelized cost of energy with tracker system; Array OmniTrack; and SmarTrack, a software product that uses site-specific historical weather and energy production data in combination with machine learning algorithms to identify the optimal position for a solar array in real time to enhance its energy production. The company was founded in 1989 and is headquartered in Albuquerque, New Mexico. | null | 478 |
US | ARTE | NGM | EQUITY | USD | Artemis Strategic Investment Corporation | Financial Services | Shell Companies | 10.66 | 189 | 76,075,928 | 2023-10-17T07:56:52.083136 | Artemis Strategic Investment Corporation does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Phoenix, Arizona. | null | 479 |
US | ARTL | NCM | EQUITY | USD | Artelo Biosciences, Inc. | Healthcare | Biotechnology | 1.44 | 45,797 | 4,126,536 | 2023-10-17T07:56:59.490531 | Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California. | null | 480 |
US | ARTNA | NMS | EQUITY | USD | Artesian Resources Corporation | Utilities | Utilities - Regulated Water | 40.86 | 20,540 | 427,186,816 | 2023-10-17T07:57:07.573772 | Artesian Resources Corporation, through its subsidiaries, provides water, wastewater, and other services in Delaware, Maryland, and Pennsylvania. The company distributes and sells water to residential, commercial, industrial, governmental, municipal, and utility customers, as well as for public and private fire protection in the states of Delaware, Maryland, and Pennsylvania; and offers wastewater collection, treatment infrastructure, and wastewater services to customers in Delaware. It also provides contract water and wastewater services; water, sewer, and internal service line protection plans; and wastewater management services, as well as design, construction, and engineering services. In addition, the company offers services to other water utilities, including operations and billing functions; owns real estate properties, including land for office buildings, a water treatment plant, and wastewater facility; and provides design, installation, maintenance, and repair services related to existing or proposed storm water management systems. As of December 31, 2022, it served approximately 94,600 customers in Delaware; 2,600 customers in Maryland; and 40 customers in Pennsylvania through 1,442 miles of transmission and distribution mains. Artesian Resources Corporation was founded in 1905 and is headquartered in Newark, Delaware. | null | 481 |
US | ARTW | NCM | EQUITY | USD | Art's-Way Manufacturing Co., Inc. | Industrials | Farm & Heavy Construction Machinery | 2.02 | 24,551 | 9,936,769 | 2023-10-17T07:57:13.427684 | Art's-Way Manufacturing Co., Inc. manufactures and sells agricultural equipment, specialized modular science buildings, and steel cutting tools in the United States and internationally. The company operates through three segments: Agricultural Products, Modular Buildings, and Tools. The Agricultural Products segment offers various specialized farm machinery, including portable and stationary animal feed processing equipment and related attachments; hay and forage equipment, such as forage boxes, bale processors, running gears, and dump boxes; manure spreaders; sugar beet harvesting equipment; dirt work equipment; and after-market service parts. The Modular Buildings segment produces, sells, and leases swine buildings, complex containment research laboratories, and research facilities for academic research institutions, government research and diagnostic centers, public health institutions, and private research and pharmaceutical companies. This segment also designs, manufactures, delivers, installs, and rents building units. The Tools segment offers standard single point brazed carbide tipped tools, polycrystalline diamond and cubic boron nitride inserts and tools, and original equipment manufacturer (OEM) specialty tools to the automotive, aerospace, oil and gas piping, and appliances industries. It markets and sells its products through independent farm equipment dealers, manufacturers representatives, direct sales, and OEM sales channels. Art's-Way Manufacturing Co., Inc. was founded in 1956 and is based in Armstrong, Iowa. | null | 482 |
US | ARVL | NMS | EQUITY | USD | Arrival | Consumer Cyclical | Auto Manufacturers | 1.11 | 95,468 | 19,932,176 | 2023-10-17T07:57:20.914779 | Arrival engages in the research and development, and design of commercial electric vehicles (EVs), EVs components, robotic manufacturing processes for EVs, and associated software in the United Kingdom, the United States, Russia, and internationally. Its products portfolio includes commercial EV vans, buses, and cars. The company was formerly known as Arrival Group S.A. and changed its name to Arrival. The company was founded in 2015 and is based in Howald, Luxembourg. Arrival is a subsidiary of Kinetik S.à r.l. | null | 483 |
US | ARVN | NMS | EQUITY | USD | Arvinas, Inc. | Healthcare | Biotechnology | 16.84 | 337,850 | 897,478,336 | 2023-10-17T07:57:28.282019 | Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. Its product pipeline includes Bavdegalutamide and ARV-766, investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer, which are in Phase 1/2 clinical trials; and ARV-471, an orally bioavailable estrogen receptor degrading PROTAC targeted protein degrader for the treatment of patients with locally advanced or metastatic estrogen receptor+/human epidermal growth factor receptor 2-breast cancer, which is Phase 3 clinical trial. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut. | null | 484 |
US | ARW | NYQ | EQUITY | USD | Arrow Electronics, Inc. | Technology | Electronics & Computer Distribution | 114.62 | 372,510 | 6,469,107,200 | 2023-10-17T07:57:35.918704 | Arrow Electronics, Inc. provides products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Global Components and Global Enterprise Computing Solutions. The Global Components segment markets and distributes semiconductor products and related services; passive, electro-mechanical, and interconnect products, including capacitors, resistors, potentiometers, power supplies, relays, switches, and connectors; and computing and memory products, as well as other products and services. The Global Enterprise Computing Solutions segment offers computing solutions, such as datacenter, cloud, security, and analytics solutions. This segment provides access to various services, including engineering and integration support, warehousing and logistics, marketing resources, and authorized hardware and software training. The company serves original equipment manufacturers, value-added resellers, managed service providers, contract manufacturers, and other commercial customers. Arrow Electronics, Inc. was founded in 1935 and is based in Centennial, Colorado. | null | 485 |
US | ARWR | NMS | EQUITY | USD | Arrowhead Pharmaceuticals, Inc. | Healthcare | Biotechnology | 26.6 | 880,156 | 2,841,686,528 | 2023-10-17T07:57:42.602152 | Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in phase 2b clinical trial for the treatment of dyslipidemia; ARO-HSD, which is completed phase 1/2 clinical trial to treat liver diseases; ARO-ENaC2, which is in pre-clinical stage for the treatment of dyslipidemia cystic fibrosis; ARO-C3 that is in phase 1/2a clinical trial to reduce production of complement component 3; ARO-DUX4, which is in pre-clinical stage for the treatment of facioscapulohumeral muscular dystrophy; ARO-XDH that is in phase 1 clinical trial to treat uncontrolled gout; ARO-COV, which is in pre-clinical stage for the treatment of COVID-19; ARO-RAGE, which is in phase 1/2a clinical trial to treat muco-obstructive or inflammatory pulmonary conditions; and ARO-MMP7 that is in phase 1/2a clinical trial for treatment of idiopathic pulmonary fibrosis. It is also involved in the development of JNJ-3989, a subcutaneously administered RNAi therapeutic candidate to treat chronic hepatitis B virus infection; Olpasiran to reduce the production of apolipoprotein A; and ARO-AMG1 for treating genetically validated cardiovascular targets. Arrowhead Pharmaceuticals, Inc. has a license and research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop JNJ-75220795, ARO-JNJ2, and ARO-JNJ3 RNAi therapeutics for liver-expressed targets; and license and research collaboration agreement with Takeda Pharmaceuticals U.S.A., Inc. to develop RNAi therapeutic candidate as a treatment for liver disease. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California. | null | 486 |
US | ARYD | NCM | EQUITY | USD | ARYA Sciences Acquisition Corp IV | Financial Services | Shell Companies | 10.89 | 15 | 86,407,896 | 2023-10-17T07:57:50.280900 | ARYA Sciences Acquisition Corp IV does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York. | null | 487 |
US | ARYE | null | null | null | null | null | null | null | null | null | null | null | error | 488 |
US | ASA | NYQ | EQUITY | USD | ASA Gold and Precious Metals Limited | Financial Services | Asset Management | 13.47 | 68,741 | 260,027,840 | 2023-10-17T07:57:56.834072 | ASA Gold and Precious Metals Limited is a publicly owned investment manager. The firm invests in the public equity markets across the globe. It primarily invests in stocks of companies engaged in the exploration, mining or processing of gold, silver, platinum, diamonds, or other precious minerals. It also invests in exchange traded funds. The firm employs fundamental analysis with a bottom-up approach to create its portfolios. The firm obtains external research to complement its in-house research. The firm is focused on covering the metals and mining sector. This record reflects the investment preferences or overall investment strategy of ASA Gold and Precious Metals Limited. ASA Gold and Precious Metals Limited was founded in 1958 and is based in Portland, Maine. | null | 489 |
US | ASAI | NYQ | EQUITY | USD | Sendas Distribuidora S.A. | Consumer Defensive | Grocery Stores | 11.5 | 505,932 | 3,316,572,672 | 2023-10-17T07:58:02.886192 | Sendas Distribuidora S.A. engages in the retail and wholesale sale of food products, bazaar items, and other products in Brazil. The company serves restaurants, pizzerias, snack bars, schools, small businesses, religious institutions, hospitals, hotels, grocery stores, neighborhood supermarkets, and individuals. It sells its products through brick-and-mortar stores, as well as through telesales. The company was founded in 1974 and is headquartered in Rio de Janeiro, Brazil. | null | 490 |
US | ASAN | NYQ | EQUITY | USD | Asana, Inc. | Technology | Software - Application | 17.58 | 2,531,675 | 4,075,026,688 | 2023-10-17T07:58:08.915537 | Asana, Inc., together with its subsidiaries, operates a work management platform for individuals, team leads, and executives in the United States and internationally. Its platform helps organizations to orchestrate work from daily tasks to cross-functional strategic initiatives; and manages product launches, marketing campaigns, and organization-wide goal settings. The company serves customers in various industries, such as technology, retail, education, non-profit, government, healthcare, hospitality, media, manufacturing, professional services, and financial services. The company was formerly known as Smiley Abstractions, Inc. and changed its name to Asana, Inc. in July 2009. Asana, Inc. was incorporated in 2008 and is headquartered in San Francisco, California. | null | 491 |
US | ASB | NYQ | EQUITY | USD | Associated Banc-Corp | Financial Services | Banks - Regional | 16 | 1,479,178 | 2,491,705,600 | 2023-10-17T07:58:14.686022 | Associated Banc-Corp, a bank holding company, provides various banking and nonbanking products to individuals and businesses in Wisconsin, Illinois, and Minnesota. The company operates through three segments: Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. Its Corporate and Commercial Specialty segment offers lending solutions, including commercial loans and lines of credit, commercial real estate financing, construction loans, letters of credit, leasing, asset based lending, and loan syndications; deposit and cash management solutions, such as commercial checking and interest-bearing deposit products, cash vault and night depository services, liquidity solutions, payables and receivables solutions, and information services; specialized financial services such as interest rate risk management, foreign exchange solutions, and commodity hedging; fiduciary services such as administration of pension, profit-sharing and other employee benefit plans, fiduciary and corporate agency services, and institutional asset management; and investable funds solutions such as savings, money market deposit accounts, IRA accounts, CDs, fixed and variable annuities, full-service, discount and online investment brokerage; investment advisory services; and trust and investment management accounts. The company's Community, Consumer, and Business segment offers lending solutions, such as residential mortgages, home equity loans and lines of credit, personal and installment loans, auto loans, business loans, and business lines of credit; and deposit and transactional solutions such as checking, credit, debit and pre-paid cards, online banking and bill pay; and money transfer services. Associated Banc-Corp was founded in 1861 and is headquartered in Green Bay, Wisconsin. | null | 492 |
US | ASC | NYQ | EQUITY | USD | Ardmore Shipping Corporation | Industrials | Marine Shipping | 13.15 | 674,996 | 560,381,248 | 2023-10-17T07:58:20.699993 | Ardmore Shipping Corporation engages in the seaborne transportation of petroleum products and chemicals worldwide. As of March 15, 2023, the company operated a fleet of 22 owned vessels including 21 Eco-design and 1 Eco-mod vessel, and five chartered-in vessels. It serves oil majors, oil companies, oil and chemical traders, chemical companies, and pooling service providers. The company was founded in 2010 and is headquartered in Pembroke, Bermuda. | null | 493 |
US | ASCA | NCM | EQUITY | USD | A SPAC I Acquisition Corp. | Financial Services | Shell Companies | 10.82 | 5,977 | 59,042,316 | 2023-10-17T07:58:29.140452 | A SPAC I Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology, media, and telecom industries in the United States and Asia. A SPAC I Acquisition Corp. was incorporated in 2021 and is based in Singapore. | null | 494 |
US | ASCB | NGM | EQUITY | USD | A SPAC II Acquisition Corporation | Financial Services | Shell Companies | 10.975 | 16 | 80,077,992 | 2023-10-17T07:58:34.853298 | A SPAC II Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to pursue prospective targets that are in the industries that apply technologies, such as Proptech and Fintech in North America, Europe, and Asia. The company was incorporated in 2021 and is based in Singapore. A SPAC II Acquisition Corporation operates as a subsidiary of A SPAC II (Holdings) Corp. | null | 495 |
US | ASEA | PCX | ETF | USD | Global X FTSE Southeast Asia ETF | null | null | 14.42 | 17,565 | 42,293,404 | 2023-10-17T07:58:40.835751 | The fund invests at least 80% of its total assets in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index tracks the equity performance of the 40 largest and most liquid companies in the five Association of Southeast Asian Nations ("ASEAN") regions: Singapore, Malaysia, Indonesia, Thailand and the Philippines. It is non-diversified. | null | 496 |
US | ASG | NYQ | EQUITY | USD | Liberty All-Star Growth Fund, Inc. | Financial Services | Asset Management | 4.8 | 176,793 | 284,196,576 | 2023-10-17T07:58:47.693698 | Liberty All-Star Growth Fund, Inc. is a closed-ended equity mutual fund launched and managed by ALPS Advisers, Inc. It is co-managed by Weatherbie Capital, LLC, Congress Asset Management Company, and Sustainable Growth Advisers, LP. The fund invests in the public equity markets of the United States. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in growth stocks of companies across all market capitalizations. It employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Composite Index, Russell 3000 Growth Index, and the S&P 500 Index. It conducts in-house research to make its investments. The fund was previously known as Charles Allmon Trust, Inc. Liberty All-Star Growth Fund, Inc. was formed on March 14, 1986 and is domiciled in the United States. | null | 497 |
US | ASGI | NYQ | EQUITY | USD | Abrdn Global Infrastructure Income Fund | null | null | 15.49 | 98,083 | 393,727,104 | 2023-10-17T07:58:55.448390 | null | null | 498 |
US | ASGN | NYQ | EQUITY | USD | ASGN Incorporated | Technology | Information Technology Services | 82.25 | 192,482 | 4,050,596,096 | 2023-10-17T07:59:03.011685 | ASGN Incorporated provides information technology services and professional solutions in the technology, digital, and creative fields for commercial and government sectors in the United States, Canada, and Europe. It operates through two segments, Commercial and Federal Government. The Commercial Segment provides consulting, creative digital marketing, and permanent placement services primarily to enterprise clients. This segment also offers workforce mobilization, modern enterprise, and digital innovation IT consulting services; and cloud, data and analytics, and digital transformation solutions. The Federal Government Segment provides mission-critical solutions to the department of defense, intelligence agencies, and civilian agencies. This segment offers cloud, cybersecurity, artificial intelligence, machine learning, application and IT modernization, and science and engineering solutions. The company was formerly known as On Assignment, Inc. and changed its name to ASGN Incorporated in April 2018. ASGN Incorporated was founded in 1985 and is based in Glen Allen, Virginia. | null | 499 |
US | ASH | NYQ | EQUITY | USD | Ashland Inc. | Basic Materials | Specialty Chemicals | 75.93 | 375,316 | 3,954,780,416 | 2023-10-17T07:59:10.528899 | Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware. | null | 500 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.